Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This paper presents new evidence on the levels and trends of vaccine hesitancy in developing countries based on harmonized high-frequency phone surveys from more than 120,000 respondents in 53 low- and middle-income countries. These countries represent a combined 30 percent of the population of low- and middle-income countries. On average across countries, one in five adults is hesitant about the COVID-19 vaccine, with the most cited reasons for hesitancy being concerns about the safety of the vaccine, followed by concerns about its efficacy. Between late 2020 and the first half of 2021, there tended to be little change in levels of hesitancy except in Iraq, Malawi, and Uzbekistan, where hesitancy increased. COVID-19 vaccine hesitancy is higher among female, young, less educated, and rural respondents, after controlling for selected observable characteristics. Country estimates of vaccine hesitancy from the high-frequency phone surveys are correlated with but lower than those from earlier studies, which often relied on less representative survey samples. The results suggest that vaccine hesitancy in developing countries, while less prevalent than previously thought, will be an important and enduring obstacle to recovery from the pandemic.

COVID-19 vaccines.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The WHO Newsletter No. 6, 2020, is a publication by the World Health Organization aimed at disseminating regulatory information on the safety of medicines. It provides updates on legal actions taken by regulatory authorities globally, safety signals from the WHO global database, and features on COVID-19 vaccine safety. The newsletter covers various pharmaceutical regulatory matters, including safety updates on drugs like asparaginase, cytarabine, and dolutegravir. It targets healthcare professionals, regulatory bodies, and stakeholders interested in drug safety and pharmacovigilance, offering insights into adverse drug reactions and new safety guidelines.

Pharmacovigilance. --- COVID-19 vaccines.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information on this disease in 2 volumes. Readers will find a concise and visual reference for this viral disease and will be equipped with the knowledge to assess and manage Sar-Cov-2 infection cases in clinical settings. This book is divided into two parts (I and II). Part I provides comprehensive information about 1 History of Coronaviruses, 2 Epidemiology of COVID-19, 3 Clinical presentation of this viral disease and 4 COVID-19 diagnosis. Part II covers broader topics about this communicable disease including 1 the prevention and treatment methodology, 2 mortality and long-term complications, 3 COVID-19 vaccines and future perspectives. Key Features: - Covers all the aspects of COVID-19 making this a perfect textbook for virology and medical students. -Chapter wise description and segregation of topics from pathophysiology to diagnosis and management of COVID-19. -Six chapters in the first part which focus on clinical basics of COVID-19. -Six chapters in the second part which cover broader topics for practical infection control. -Multiple tables and figures which summarize and highlight important points. -Presents a summary of the current standards for the evaluation and diagnosis of COVID-19. - Features a detailed list of references, abbreviations, and symbols. This book is an essential textbook reference for medical students, scientists (virologists, pulmonologists) and public health officials who are required to understand COVDI-19 diagnosis and management as part of their clinical training or professional work.

Covid-19 vaccines. --- Public policy. --- Communicable Diseases --- Medical

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

COVID-19 vaccines --- Vaccins contre la COVID-19 --- COVID-19 vaccines --- Vaccins contre la COVID-19 --- Comparative law --- Droit comparé --- Law and legislation. --- Droit --- Patents. --- Brevets d'invention

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

COVID-19 Pandemic, 2020 --- -COVID-19 (Disease) --- COVID-19 vaccines. --- Social aspects. --- Prevention.